Could FAP-Targeted Molecular Imaging Replace18F-FDG for Standard-of-Care Oncologic PET?
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2023/02/02
-
Journal
-
Indian UGC (journal)
-
Refrences15
-
Raghava Kashyap
-
Aravind S. Ravi Kumar
Cite
Kashyap, Raghava, and Aravind S. Ravi Kumar. “Could FAP-Targeted Molecular Imaging Replace18F-FDG for Standard-of-Care Oncologic PET?”. Journal of Nuclear Medicine, vol. 64, no. 4, 2023, pp. 623-4, https://doi.org/10.2967/jnumed.122.265003.
Kashyap, R., & Ravi Kumar, A. S. (2023). Could FAP-Targeted Molecular Imaging Replace18F-FDG for Standard-of-Care Oncologic PET?. Journal of Nuclear Medicine, 64(4), 623-624. https://doi.org/10.2967/jnumed.122.265003
Kashyap R, Ravi Kumar AS. Could FAP-Targeted Molecular Imaging Replace18F-FDG for Standard-of-Care Oncologic PET?. Journal of Nuclear Medicine. 2023;64(4):623-4.
Journal Categories
Medicine
Medicine (General)
Medicine
Medicine (General)
Medical physics
Medical radiology
Nuclear medicine
You May Also Like
- Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
- Low density of sigma1 receptors in early Alzheimer’s disease
- Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Prospective Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Tumor Staging in Biliary Tract Cancers | Radiology |
| 21 | 2022 |
| Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging | Seminars in Cancer Biology |
| 33 | 2022 |
| [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT | European Journal of Nuclear Medicine and Molecular Imaging |
| 38 | 2022 |
| Hetero-bivalent agents targeting FAP and PSMA | European Journal of Nuclear Medicine and Molecular Imaging |
| 15 | 2022 |
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy | European Journal of Nuclear Medicine and Molecular Imaging |
| 60 | 2022 |